Comparison of bevacizumab, ranibizumab and aflibercept in retinopathy of prematurity treatment. Suren E, Ozkaya D, Cetinkaya E, Kalayci M, et al. Int Ophthalmol 2022 Jan 30. pii: 10.1007/s10792-021-02188.

Read + Share

Amedeo Smart

Independent Medical Education

Suren E, Ozkaya D, Cetinkaya E, Kalayci M, et al. Comparison of bevacizumab, ranibizumab and aflibercept in retinopathy of prematurity treatment. Int Ophthalmol 2022 Jan 30. pii: 10.1007/s10792-021-02188.
PMID: 35094229